Goldman Sachs
TMDX icon

Goldman Sachs’s Transmedics TMDX Stock Holding History

Goldman Sachs’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,400
Closed -$3.54M – 6655
2025
Q2 		$3.54M Buy
+26,400
New +$2.9M ﹤0.01% 3727

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Goldman Sachs's TMDX Position: Q2 2026 in Review

Goldman Sachs reduced its Transmedics (TMDX) stake by 35% in Q2 2026, selling an estimated $25.9M and leaving 559,771 shares worth $37.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2062.

Goldman Sachs first reported a position in TMDX in Q1 2020 and has held it in 26 quarters since. The position peaked at $118M in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Goldman Sachs held 559,771 shares of Transmedics worth $37.2M as of Q2 2026.
  • Goldman Sachs sold 306,511 Transmedics shares in Q2 2026, an estimated $25.9M.
  • Transmedics made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2062 holding.
  • Goldman Sachs first reported a position in Transmedics in Q1 2020 and has held it in 26 quarters since.
  • Goldman Sachs's Transmedics position peaked at $118M in Q4 2025.
  • 375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.